| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 08/13/2008 | EP1954653A2 Method of generating amorphous solid for water-insoluble pharmaceuticals |
| 08/13/2008 | EP1954132A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 08/13/2008 | EP1452528B1 Xanthine oxidase inhibitors |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | CN101243054A Synergistic composition amd method for inhibiting growth of microorganisms |
| 08/13/2008 | CN100411219C Molecular-base electric double-stable negative-resistance component and its application |
| 08/12/2008 | US7411098 Aldol condensation of citral with acetone and subsequent hydrogenation; using tetrahydrogeranylacetone for preparing phytol, isophytol, tocopherol and/or tocopherol derivatives |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7410990 Heterocyclic compounds |
| 08/12/2008 | US7410989 intravenous or oral administration of viricides against the Flaviviridae family of viruses; e.g. 2-[5(6)-Amidino-2-benzimidazoyl]-5-(4-nitrophenyl)furan |
| 08/07/2008 | WO2008093742A1 Process for production of binuclear metal complex |
| 08/07/2008 | WO2008093614A1 Novel hepatitis c virus inhibitor |
| 08/07/2008 | WO2008092879A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 08/07/2008 | WO2008092878A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 08/07/2008 | WO2008092874A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 08/07/2008 | WO2008092872A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 08/07/2008 | US20080188668 Process for preparing substituted benzimidazole compounds |
| 08/07/2008 | US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist; |
| 08/06/2008 | EP1953146A1 Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl) amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form |
| 08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
| 08/06/2008 | EP1951714A1 Process for producing 2-(n-butyl)-3-[[2'-(tetrazol-5-yl)biphenyl- 4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one |
| 08/06/2008 | EP1907366A4 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
| 08/06/2008 | EP1660491B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 08/06/2008 | EP1236712B1 Amidinophenylpyruvic acid derivative |
| 08/06/2008 | CN101238110A Heterocyclic compounds as agonists for the thyroid receptor |
| 08/06/2008 | CN101235017A Method for preparing benzimidazole |
| 08/06/2008 | CN100407922C Antimicrobial additive and ink composition containing said additive |
| 08/05/2008 | US7407968 Compounds |
| 08/05/2008 | US7407960 e.g. 2-{4-[(2R)-2-hydroxy-3-(2-methylbenzothiazol-5-yloxy)propyl]piperazinyl}-N-((1S)-1-phenylethyl)acetamide; fatty acid oxidation inhibitor; cardiovascular diseases: atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's angina, stable and unstable angina, and diabetes |
| 08/05/2008 | CA2417081C New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 08/05/2008 | CA2226184C A process for the optical purification of enantiomerically enriched benzimidazole derivatives |
| 07/31/2008 | WO2008057775A3 Heterocyclic amide compounds useful as kinase inhibitors |
| 07/31/2008 | WO2007127010A3 Diarylthiohydantoin compounds |
| 07/31/2008 | US20080181923 Dentifrices; stents; catheters; grafts |
| 07/30/2008 | EP1948616A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 07/30/2008 | CN101233116A Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same |
| 07/30/2008 | CN101233115A Indole and benzimidazole derivatives |
| 07/30/2008 | CN100406427C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 07/29/2008 | US7405235 Benzimidazoles for antibiotic resistance of cells |
| 07/29/2008 | US7405234 Bicyclic modulators of androgen receptor function |
| 07/29/2008 | US7405229 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2205811C Multifunctional cyanate ester and epoxy blends |
| 07/24/2008 | WO2008089459A1 Inhibitors of mek |
| 07/24/2008 | WO2007134169A9 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof |
| 07/24/2008 | WO2007120638A3 Methods and compositions for modulating glycosylation |
| 07/24/2008 | US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/24/2008 | US20080177016 radiation curable aromatic olefins, acrylic polymers, vinyl esters or vinyl ether polymers, functionalized with chromogens, used for dispersion of inks, capable of producing images of high image quality with a high optical density |
| 07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/24/2008 | CA2675358A1 Inhibitors of mek |
| 07/23/2008 | EP1044199B1 Heterocyclic topoisomerase poisons |
| 07/23/2008 | CN100404536C Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/23/2008 | CN100404535C Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 07/23/2008 | CN100404529C 2,4-bis (trifluoroethoxy)pyridine compound and drug containing the compound |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/17/2008 | WO2008085008A1 T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases |
| 07/17/2008 | WO2008084717A1 Tricyclic compound and pharmaceutical use thereof |
| 07/17/2008 | WO2008017020A3 Process for preparing proton pump inhibitors |
| 07/17/2008 | US20080171778 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/17/2008 | US20080171770 e.g. 2-(6,7-difluoro-1H-benzimidazol-1-yl)-N-{1-[4-(trifluoromethyl)phenyl]ethyl}aceta mide; vanilloid receptor 1 (VR1 or TRPV1) antagonist; antiinflammatory agent; neuropathic pain; arthritis, ischaemia, fibromyalgia, asthma, cough, inflammatory bowel disease, obesity |
| 07/17/2008 | CA2674045A1 Tricyclic compound and pharmaceutical use thereof |
| 07/16/2008 | EP1944311A1 Benzimidazole compounds and their use as chromatographic ligands |
| 07/16/2008 | EP1943230A2 Compounds which have activity at m1 receptor and their uses in medicine |
| 07/16/2008 | EP1943229A1 Benzimidazole derivatives for use as beta-3 receptor agonists |
| 07/16/2008 | EP1943226A2 Phenol ethers as modulators of the opioid receptors |
| 07/16/2008 | EP1392655B1 Potassium channel openers |
| 07/16/2008 | CN101223145A Nitrogen-containing heterocyclic derivative having electron-attracting substituent and organic electroluminescence element using the same |
| 07/16/2008 | CN101223136A New benzoheterocyclylethylbenzamide derivatives |
| 07/16/2008 | CN101222922A Diarylhydantoin compounds |
| 07/16/2008 | CN101220033A Synthesis of temozolomide and analogs |
| 07/16/2008 | CN100402529C Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders |
| 07/16/2008 | CN100402528C Urea substituted imidazopyridines |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/15/2008 | US7399776 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
| 07/15/2008 | US7399775 β-amyloid protein production/secretion inhibitor |
| 07/15/2008 | CA2355856C Method for production of polyelectrolyte membranes and fuel cell |
| 07/10/2008 | WO2008082003A1 Fused heterocyclic compounds having crf antagonistic activity |
| 07/10/2008 | WO2008052072A9 Compounds for the treatment of pain and screening methods therefor |
| 07/10/2008 | WO2008048991A3 Organic compounds |
| 07/10/2008 | US20080167359 guanidines such as (1H-benzoimidazol-2-yl)(2,6-dichlorophenyl)methylamine, used as proton pump inhibitors for prevention or treatment of respiratory system, sleep, urogenital or nervous ststem disorders; as antihypotensive, neuroleptic, antidepressants, anxiolytic, antiischemic or antilipemic agents |
| 07/10/2008 | US20080167341 1H-Benzimidazol-2-yl methyl)-piperidin-3-ylmethyl-(5,6,7,8-tetrahydro-quinolin-8-yl)-amine; fusin and chemokine receptors antagonist/agonist; increase progenitor and/or stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 07/10/2008 | US20080167306 Novel Heteroaryl Derivative |
| 07/09/2008 | EP1942101A1 Secretase inhibitor |
| 07/09/2008 | EP1940776A2 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 07/09/2008 | EP0984969B1 Fused dihydropyrans |
| 07/09/2008 | CN101218209A Benzimidazole derivatives for treatment of inflammatory diseases |
| 07/09/2008 | CN101218208A Nitrogen-containing heterocyclic derivative and organic electroluminescence element using the same |
| 07/09/2008 | CN100400536C Process for preparing candesartan cilexetil C-form crystal |
| 07/09/2008 | CN100400517C Process for synthesizing methyl mercapto benizmidazole by using TDI byproducts |
| 07/08/2008 | US7396615 Immersing a basic polymer such as a polybenzimidazole in a strong acid having a concentration sufficient to impregnate the basic polymer with six or more strong acid molecules per polymer repeating unit of the basic polymer |
| 07/03/2008 | WO2008019030A3 Modified azole compounds as antiinfective agents |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161326 Novel Sulfone Amide Amide Derivatives |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080160521 Benzimidazolium dyes and their use as fluorescent chemosensors |
| 07/02/2008 | WO2007087518A2 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |